wiki pageCreated: 2026-04-02T07:19:23By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-genes-cln6
📖 Wiki Page
gene771 wordssynced 2026-04-02
CLN6 Gene
Introduction
Cln6 Gene Ceroid Lipofuscinosis, Neuronal 6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value | [@trondle2022] |-----------|-------| | Gene Symbol | CLN6 | | Gene Name | Ceroid Lipofuscinosis, Neuronal 6 | | Official Full Name | CLN6, Endoplasmic Reticulum Lysosomal Trafficking Protein | | Chromosomal Location | 15q23 | | GRCh38 Coordinates | chr15:68,519,153-68,537,792 | | NCBI Gene ID | 2569 | | OMIM ID | 606725 | | Ensembl ID | ENSG00000154553 | | UniProt ID | Q9NWW3 | | Gene Family | CLN6 family, ER membrane proteins |
</div>}
Overview
The CLN6 gene encodes an endoplasmic reticulum (ER) membrane protein that is essential for lysosomal function and autophagy. CLN6 forms a complex with CLN8 and other proteins to mediate ER-to-lysosome trafficking. Mutations in CLN6 cause variant forms of neuronal ceroid lipofuscinosis (NCL), including late infantile and adult-onset forms<sup>[1]</sup>.
Function
Protein Structure
CLN6 is a 311-amino acid transmembrane protein (34 kDa) residing in the ER membrane. It contains multiple transmembrane domains and cytosolic N- and C-termini<sup>[2]</sup>.
Normal Physiological Roles
...
CLN6 Gene
Introduction
Cln6 Gene Ceroid Lipofuscinosis, Neuronal 6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Attribute | Value | [@trondle2022] |-----------|-------| | Gene Symbol | CLN6 | | Gene Name | Ceroid Lipofuscinosis, Neuronal 6 | | Official Full Name | CLN6, Endoplasmic Reticulum Lysosomal Trafficking Protein | | Chromosomal Location | 15q23 | | GRCh38 Coordinates | chr15:68,519,153-68,537,792 | | NCBI Gene ID | 2569 | | OMIM ID | 606725 | | Ensembl ID | ENSG00000154553 | | UniProt ID | Q9NWW3 | | Gene Family | CLN6 family, ER membrane proteins |
</div>}
Overview
The CLN6 gene encodes an endoplasmic reticulum (ER) membrane protein that is essential for lysosomal function and autophagy. CLN6 forms a complex with CLN8 and other proteins to mediate ER-to-lysosome trafficking. Mutations in CLN6 cause variant forms of neuronal ceroid lipofuscinosis (NCL), including late infantile and adult-onset forms<sup>[1]</sup>.
Function
Protein Structure
CLN6 is a 311-amino acid transmembrane protein (34 kDa) residing in the ER membrane. It contains multiple transmembrane domains and cytosolic N- and C-termini<sup>[2]</sup>.
Normal Physiological Roles
ER-Lysosome Trafficking: Mediates protein transport between ER and lysosomes
Lysosomal Enzyme Activation: Regulates lysosomal function
[Autophagy](/entities/autophagy): Participates in autophagic pathways
Lipid Metabolism: Involved in lipid homeostasis
Neuronal Survival: Critical for neuronal health
Molecular Interactions
CLN6 interacts with:
CLN8 - ER-lysosomal trafficking complex
ER export machinery - COPII vesicles
Lysosomal proteins - Functional interactions
Autophagy proteins - Regulation of degradation
Disease Associations
CLN6 Disease (Variant Late Infantile NCL)
CLN6 mutations cause NCL with variable phenotypes<sup>[1]</sup>:
| Feature | Onset | Progression | |---------|-------|-------------| | Vision loss | 3-8 years | Progressive retinal degeneration | | Seizures | 3-8 years | Myoclonic, generalized | | Cognitive decline | 3-8 years | Progressive dementia | | Motor dysfunction | 4-10 years | Ataxia, spasticity | | Speech loss | 4-10 years | Progressive | | Death | 8-25 years | Variable |
Adult-Onset Variant (Kufs Disease)
Some CLN6 mutations cause adult-onset NCL (Kufs disease), characterized by:
Tissue Distribution: High in brain ([cortex](/brain-regions/cortex), cerebellum), retina
Brain Regions: Expressed in [neurons](/entities/neurons)
Cellular Localization: ER membrane
Developmental Expression: Throughout development
Transcript: 1.7 kb mRNA, 7 exons
Therapeutic Approaches
Current Treatments
Anticonvulsants: Seizure management
Supportive care: Multidisciplinary approach
Physical/occupational therapy: Maintain function
Experimental Therapies
Gene therapy: AAV-vector approaches in development
Small molecule approaches: Being investigated
Protein replacement: Challenging due to ER localization
Research Directions
Understanding CLN6 function in ER-lysosome trafficking
Developing gene therapy approaches
Characterizing genotype-phenotype correlations
Identifying therapeutic targets
Background
The study of Cln6 Gene Ceroid Lipofuscinosis, Neuronal 6 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
[Allen Human Brain Atlas - CLN6 Expression](https://human.brain-map.org/microarray/search/show?search_term=CLN6) — Gene expression data across human brain regions
[Allen Cell Type Atlas - CLN6](https://celltype.brain-map.org/) — Single-cell expression data